Learning Objectives:
1. Defining statin intolerance
2. Discuss alternative therapies in the new area of PCSK9 Inhibitors, Inclisiran, Ezetimibe and Bempedoic Acid and what to choose for your patients.
Session date:
10/04/2024 - 7:30am to 8:30am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Dr. Victor Macrinici